Recent advances in the study of bioreductive drugs targeted tumor hypoxia / 药学学报
Acta Pharmaceutica Sinica
;
(12): 695-702, 2009.
Artigo
em Chinês
| WPRIM
| ID: wpr-278197
ABSTRACT
Tumor hypoxia is the necessary process in the development of solid tumors, which is the key factor for drug resistance, recurrence, attack and shift of tumor. Hypoxic tumor cells have a certain extent of tolerance to radiation and chemotherapy. Tumor hypoxia is an important target for medication therapy. In the recent years, the bioreductive drugs targeted tumor hypoxia has made great process in the treatment of tumors. The latest advances of bioreductive drugs targeted hypoxia were reviewed in this paper.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Quinonas
/
Hipóxia Celular
/
Substâncias Redutoras
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Hipóxia
/
Neoplasias
/
Antineoplásicos
Limite:
Humanos
Idioma:
Chinês
Revista:
Acta Pharmaceutica Sinica
Ano de publicação:
2009
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS